Expression of CD40 and Its Ligand, CD40L, in Intestinal Lesions of Crohn's Disease

Battaglia, Edda; Biancone, Luigi; Resegotti, Andrea; Emanuelli, Giorgio; Fronda, Gian Ruggero; Camussi, Giovanni
November 1999
American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3279
Academic Journal
OBJECTIVE; Selected mechanisms of the immune system participate in the development of inflammatory bowel disease. Recently, overexpression of the ligand for CD40 (CD40L), a lymphocyte costimulatory molecule, was shown to induce severe inflammatory bowel disease in transgenic mice. In the present study, we examined the expression of CD40 and CD40L on surgical specimens of ileum from 12 patients with Crohn's disease and 10 patients with diverticulitis. METHODS: Several CD40L+ cells were present in the affected (issue of patients with Crohn's disease, whereas few scattered CD40L+ cells were detected in sections of histologically normal ileum, resected distantly from the affected tissue, in patients with diverticulitis and in normal ileum portions obtained from colorectal cancer undergoing extensive surgery. The phenotype of CD40L+ cells was mainly CD4+. RESULTS: In patients with Crohn's disease, several CD40+ cells were detectable in the same areas of lymphocytes expressing CD40L, whereas in patients with diverticulitis, the number of CD40+ cells was significantly lower. Most of the CD40+ cells costained with CD20, thus showing to be B-lymphocytes, and only a few were CD14+ macrophages. Several von Willebrand-positive vessels were also positive for CD40. In addition, several infiltrating macrophages were found to express B7-1 and B7-2 molecules, the ligands of CD28 and CTLA-4, which cooperate with the CD40-CD40L pathway in lymphocyte activation. Staining of ileal lesions with anti-CTLA-4 antibodies resulted in detection of none or very few positive cells. In contrast, in patients with diverticulitis, an enhanced number of B7-1 and B7-2 and CTLA-4 was observed. CONCLUSION: The local accumulation of CD40L+ together with CD40+ cells within intestinal lesions of Crohn's disease suggests the involvement of this co-stimulatory pathway.


Related Articles

  • Evaluation of the immunoregulatory activity of intraepithelial lymphocytes in a mouse model of chronic intestinal inflammation. Ostanin, D. V.; Brown, C. M.; Gray, L.; Bharwani, S.; Grisham, M. B. // International Immunology;Dec2010, Vol. 22 Issue 12, p927 

    Intraepithelial lymphocytes (IELs) represent the first line of lymphocyte defense against the intestinal bacteria. Although previous studies have demonstrated a protective role of IELs in the development of colitis, the data supporting a regulatory role for IELs are limited. The objective of...

  • Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies? Pizarro, T. T.; de la Rue, S. A.; Cominelli, F. // Gut;Sep2006, Vol. 55 Issue 9, p1226 

    The article focuses on the significance of interleukin 6 (IL-6) in Crohn's ileitis in the murine model SAMP/Yit. Research revealed that administration of hyper IL-6 increased the severity of the disease in the mice. On the other hand, treatment with an inhibitor of IL-6 improves the severity of...

  • Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Yoshihara, K.; Yajima, Toshiki; Kubo, C.; Yoshikai, Y. // Gut;Mar2006, Vol. 55 Issue 3, p334 

    Background and aims: Interleukin (IL)-15 is a member of the IL-2 family, stimulating dendritic cells, natural killer (NK) cells, NK T cells and memory CD8+ T cells. IL-15 levels were elevated in the intestinal mucosa of inflammatory bowel diseases. Here we investigated the involvement of IL-15...

  • Mucosal immunology: Don't forget our fungal friends. Minton, Kirsty // Nature Reviews Immunology;Jul2012, Vol. 12 Issue 7, p476 

    The article presents the study that investigates the importance of commensal fungi in the immune system. Researchers studied and analyzed the interactions of fungi inside the intestinal immune system using a mouse model and they found that the presence of fungi in the gut are associated with...

  • Cancer: IL-22: linking inflammation and cancer. Harrison, Charlotte // Nature Reviews Drug Discovery;Jul2013, Vol. 12 Issue 7, p504 

    The article discusses research being done on the role of interleukin-22 (IL-22) in the transition from intestinal inflammation to cancer. It references a study by S. Kirchberger et al published in a 2013 issue of the "Journal of Experimental Medicine." Mice served as subjects in this study....

  • Systemic Infusion of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Experimental Colitis in Mice. He, Xiao-Wen; He, Xiao-Sheng; Lian, Lei; Wu, Xiao-Jian; Lan, Ping // Digestive Diseases & Sciences;Dec2012, Vol. 57 Issue 12, p3136 

    Background and Aims: The anti-inflammatory and reparative properties of mesenchymal stem cells (MSCs) make them a promising tool for treating immune-mediated and inflammatory disorders. However, whether MSCs can be used for treatment of inflammatory bowel disease (IBD) still remains unclear. In...

  • Blockade of IL-6 signal exacerbates acute inflammatory bowel disease via inhibiting IL-17 producing in activated CD4+ Th17 population. S.-J. ZHANG; L. WANG; L. MING; X.-B. GUO; H.-M. WANG; X.-W. LI; L. LI // European Review for Medical & Pharmacological Sciences;Dec2013, Vol. 17 Issue 24, p3291 

    BACKGROUND: Inflammatory bowel disease (IBD) is a common disease in human resulted from a various of factors including genetic background, immune system and environment factors. OBJECTIVES: Recent studies suggest pro-inflammatory cytokine IL-17 producing cell subset was involved in the disease...

  • VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Bruno, Angela; D'Amore, Claudio; Distrutti, Eleonora; Fiorucci, Stefano; Sanz, Yolanda // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: Signals generated by the inflammed intestine are thought to contribute to metabolic derangement. The intestinal microbiota contributes to instructing the immune system beyond the intestinal wall and its modulation is a potential target for treating systemic disorders. Aims: To...

  • Technique: A new approach to studying tolerance. Minton, Kirsty // Nature Reviews Immunology;Apr2005, Vol. 5 Issue 4, p266 

    Discusses research being done on an immunoglobulin Cκ-reactive single chain antibody fusion protein that induces tolerance through receptor editing in a normal polyclonal immune system. Reference to a study by D. Ait-Azzouzene et al published in the 2005 issue of the "Journal of Experimental...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics